PDCD1 and cancer: Studies have found that MHC class I-deficient non-obese diabetic mice carrying human HLA-DQ8 develop severe myocarditis and myositis after treatment with anti-PD-1 immune checkpoint inhibitors for cancer (59), however, HLA-B*52:01 has not been reported in myocarditis and myositis.